Dow Up 2.00% Nasdaq Up 1.66%

More On ACT

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Allergan plc (ACT)

-NYSE
298.98 0.00(0.00%) Jun 12
Prev Close:298.98
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:348.65
Beta:0.74
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:201.91 - 317.72
Volume:0
Avg Vol (3m):2,770,570
Market Cap:117.33B
P/E (ttm):N/A
EPS (ttm):-9.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distri... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback